减轻体重. 减轻体重. 减轻体重. 减轻体重. 在肥胖患者的半星化期间,脏的矿物质和激素分泌
JAMA
|January 23, 1981
概括
在大多数参与者中,早上吃400卡路里的饮食导致了较大体重减轻,相比于晚上吃饭. 饮食时间可能会影响体重控制和荷尔蒙分泌.
科学领域:
- 代谢研究的研究.
- 时间生物学 时间生物学
- 肥胖研究的研究.
背景情况:
- 了解饮食时间对体重管理的影响对于开发有效的肥胖治疗来说至关重要.
- 外源性肥胖,通常与生活方式因素有关,需要有针对性的干预措施.
研究的目的:
- 为了研究饮食时间对外源性肥胖患者减肥的影响.
- 分析与饮食时间相关的荷尔蒙和矿物质分泌模式.
主要方法:
- 三名外源性肥胖症患者参与了这项研究.
- 持续的400卡路里饮食是每天一次的每日一顿饭.
- 连续10天的时间内,早餐时间为上午8点 (早餐协议) 或下午5点 (晚餐协议).
- 尿液样本每4小时收集一次,并对矿物质和激素进行分析.
主要成果:
- 三分之二的患者在早上8点的早餐方案中表现出更大的体重减轻,而不是晚上5点的晚餐方案.
- 患者3在两种食时间协议之间,体重减轻没有显著差异.
- 尿样分析显示,矿物质和荷尔蒙分泌的差异是根据饮食时间而有所不同.
结论:
- 这些发现暂时表明,早上 (8点) 摄入同热量饮食可能会导致更大的体重减轻.
- 吃饭的时间似乎会影响特定矿物质和激素的分泌.
- 需要使用更大的样本大小进行进一步的研究来证实这些观察.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...


